PCVX vs JNJ: Which Stock is Better?
Side-by-side comparison of Vaxcyte Inc and Johnson & Johnson in 2026
PCVX
Vaxcyte Inc
—
JNJ
Johnson & Johnson
$249.97
Key Metrics Comparison
| Metric | PCVX | JNJ | Winner |
|---|---|---|---|
| Market Cap | $6.84B | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PCVX
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCVX or JNJ a better investment?
Comparing PCVX and JNJ: Vaxcyte Inc has a market cap of $6.84B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCVX and JNJ?
PCVX (Vaxcyte Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCVX or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PCVX or JNJ?
Both PCVX and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PCVX or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PCVX or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $6.84B for PCVX.
Should I buy PCVX or JNJ in 2026?
Both PCVX and JNJ have investment merit. PCVX trades at $N/A while JNJ trades at $249.97. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCVX and JNJ stock?
Key differences: Market Cap ($6.84B vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PCVX or JNJ in 2026?
The choice between PCVX and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PCVX and JNJ?
PCVX (Vaxcyte Inc) has a market cap of $6.84B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.